VIVA Biotech Holdings

Triumvira Immunologics raises $55M in Series A funding round for new form of cancer cell therapy

The company hopes to use the money to bring its T-cell antigen coupler cell therapy technology - currently in preclinical development - into human clinical trials. German drugmaker Bayer's venture capital arm led the round.

By Alaric DeArment

These health startups raised $124M in venture capital funding this week

Although the Covid-19 pandemic has continued its relentless spread across the globe, several startup companies have closed venture capital funding rounds this week.

By Alaric DeArment

These Are the Top-Rated Autism Therapy Centers in Texas

There are a number of criteria for selecting the best autism therapy centers. Parents choosing a facility or professionals seeking to improve their offerings should consider certain standards to ensure the right fit.

By Behavioral Innovations

Immune Support on Demand: Ranking the Top Mobile IV Therapy Companies

Explore the top mobile IV therapy companies boosting immune health on demand, with standout services, expert care and innovative delivery across the U.S.

By Lone Star IV Medics

Price Transparency is the New North in the PBM World

In this episode hear how improving benefit verification, prior authorizations, and patient affordability with smart integrations and real-time eligibility can streamline healthcare workflows.

By MedCity News and Abarca